China Life Insurance Company Limited (2628.HK)
HKSE • Financial Services
October 9, 2026 at 08:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every HKD 100 in revenue, China Life Insurance Company Limited keeps HKD 46 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 19 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
China Life Insurance’s adjusted EPS topped consensus in the second fiscal quarter of 2026, with results reported August 27, 2026, as adjusted EPS of CNY 5.50 topped the CNY 5.33 estimate (+3.2%). Revenue in the quarter came in at roughly CNY 286.2 billion. The business spans life, health, and accident insurance plus other businesses across the People’s Republic of China. For the next period, consensus calls for EPS of CNY 0.98.
Next report — what to expect
China Life Insurance Company (2628.HK) reports on April 1, 2027. The next-period consensus calls for EPS of CNY 0.967 on revenue of CNY 119.69 billion. For trailing context, revenue grew +129.4% year over year last quarter. China Life has beaten EPS in 6 of 8 most recent quarters.
About China Life Insurance Company Limited
China Life Insurance Company Limited, listed on the Hong Kong Stock Exchange as 2628.HK, is a Chinese life and protection insurer. It writes life, health, and accident policies across the People's Republic of China and generated CNY 605.1 billion in FY2025 revenue.
Today's Snapshot
2628.HK closed 2.5% lower on heavier trading than usual.
Trading Volume
Above 10d avg 35.1M
47.8M
vs S&P 500 Today
Underperforming Market
-2.00%
Updated: October 9, 2026 at 08:08 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$27.50 - $28.55Sell
- RSI (14)32.02Neutral
- Stochastic %K (14, 3, 3)6.26Buy
- MACD Level (12, 26)-0.61Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.